Pain Management in the Emergency Department
Immediate Pain Assessment and Triage
All patients presenting to the ED should have pain assessed at triage using validated tools (0-10 numeric rating scale or visual analog scale), and this assessment must be repeated throughout the ED stay to determine treatment effectiveness. 1
- Patients with severe pain (score >7/10) require immediate triage to a treatment room for evaluation and analgesia 1
- Pain scores >3/10 warrant consideration of oral analgesic administration even before full physician evaluation 1
- Reassessment should occur at regular intervals (typically 30-60 minutes after intervention) to guide further treatment 1
First-Line Analgesic Selection by Pain Severity
Mild to Moderate Pain (Score 1-6/10)
For mild-moderate pain, NSAIDs (ibuprofen, naproxen) are superior to codeine-acetaminophen combinations, with a number needed to treat of 2.7 for NSAIDs versus 4.4 for codeine-acetaminophen. 1
- Ibuprofen 400-800 mg PO or ketorolac 30 mg IV/IM provides effective analgesia with longer time to re-medication 1
- Acetaminophen 650-1000 mg PO/IV every 6 hours can be used as monotherapy or combined with NSAIDs 1, 2
- Avoid NSAIDs in patients with aspirin allergy, anticipated surgery, bleeding disorders, renal disease, or post-procedural bleeding risk 1, 2
Moderate to Severe Pain (Score 7-10/10)
For severe acute pain requiring IV opioids, fentanyl (1 mcg/kg initial dose, then ~30 mcg every 5 minutes) is recommended over morphine due to faster onset, shorter duration, and 100-fold greater potency. 1
- Fentanyl has higher lipid solubility resulting in superior bioavailability and more rapid pain relief 1
- Hydromorphone 0.015 mg/kg IV is a comparable or potentially superior alternative to morphine 0.1 mg/kg IV, with quicker onset and less risk of dose-stacking toxicity 1
- If morphine is used, administer 0.1 mg/kg IV slowly (maximum 10 mg), then 0.05 mg/kg at 30 minutes 1, 3
- Rapid IV administration of morphine may cause chest wall rigidity and must be avoided 3
Critical Contraindications and Safety Considerations
Absolute Contraindications to Opioids
- Respiratory depression without resuscitative equipment immediately available 3
- Acute or severe bronchial asthma or hypercarbia 3
- Known or suspected paralytic ileus 3
- Known hypersensitivity to the specific opioid 3
High-Risk Populations Requiring Dose Adjustment
Patients with hepatic cirrhosis or renal failure require significantly lower starting doses of opioids with slow titration and careful monitoring for side effects. 3
- Start with 50% of standard dose in severe renal impairment (CrCl <30 mL/min) 3
- Morphine accumulates active metabolites in renal dysfunction; fentanyl or hydromorphone are preferred alternatives 1, 2
- Elderly patients require lower initial doses due to altered pharmacokinetics and increased sensitivity 4
Drug Allergy Management
Patients with morphine allergies do not have cross-reactivity with fentanyl and can safely receive fentanyl for analgesia. 1
- For NSAID hypersensitivity, challenge with COX-2 inhibitors (celecoxib) is typically tolerated 1
- If specific NSAID allergy is suspected, use an NSAID from a different structural group 1
- Acetaminophen provides safe alternative analgesia without cross-reactivity to NSAIDs 1, 2
Multimodal Analgesia Strategy
Combining analgesics from different mechanistic classes (balanced analgesia) reduces individual drug doses and overall side effect burden while improving pain control. 5, 6
- Acetaminophen 1000 mg IV/PO + ibuprofen 600-800 mg PO provides synergistic analgesia for musculoskeletal pain 1
- For severe pain, combine non-opioid baseline analgesia (acetaminophen + NSAID) with titrated opioid doses 5, 6
- Regional anesthesia techniques (nerve blocks, topical anesthetics) should be considered to minimize systemic analgesic requirements 1
Procedure-Related Pain Control
Topical Anesthesia for Minor Procedures
Topical anesthetics should be applied proactively for any patient with high likelihood of requiring non-emergent invasive procedures on intact skin (IV placement, venipuncture, lumbar puncture, abscess drainage). 1
- Liposomal 4% lidocaine cream (LMX4) provides anesthesia in approximately 30 minutes 1
- Heat-activated systems reduce time required to 10-20 minutes 1
- EMLA cream requires 60 minutes for adequate anesthesia 1
Discharge Analgesia Protocols
Patients discharged from the ED should receive scheduled non-opioid analgesia for 48 hours, then as-needed dosing, rather than opioid-only prescriptions. 2
- Acetaminophen 1000 mg PO every 6 hours scheduled for 48 hours, then PRN 2
- Ibuprofen 600 mg PO every 6 hours with food for 3-5 days for musculoskeletal injuries 1
- If opioids are necessary, prescribe the minimum effective dose for the shortest duration (typically ≤3 days) 7
- All patients on opioids require prophylactic laxative prescriptions to prevent constipation 4
Common Pitfalls to Avoid
- Never delay analgesia pending diagnostic workup - pain control does not mask surgical findings and improves patient cooperation 1
- Avoid combining opioids with benzodiazepines or gabapentinoids outside monitored settings due to compounded respiratory depression risk 4
- Do not use NSAIDs post-endoscopy or in patients with active GI bleeding - they increase bleeding risk and can mask perforation signs 2
- Never administer morphine rapidly IV - slow injection over 4-5 minutes prevents chest wall rigidity 3
- Avoid morphine in elderly or renally impaired patients - active metabolites accumulate causing prolonged sedation and respiratory depression 1, 4
Monitoring and Reassessment Requirements
Pain scores, vital signs, sedation level, and respiratory status must be documented before and after each analgesic intervention. 1
- Reassess pain 30 minutes after oral medication, 15 minutes after IV medication 1
- Monitor for adverse effects including respiratory depression, hypotension, nausea, and altered mental status 3
- Have naloxone immediately available whenever administering opioids 3
- Document pain trajectory and response to treatment in medical record 1